Kiniksa Pharmaceuticals International Plc (KNSA)
41.49
+0.94
(+2.33%)
USD |
NASDAQ |
Dec 11, 15:27
Kiniksa Pharmaceuticals International Shareholders Equity (Quarterly): 535.38M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CorMedix, Inc. | 374.13M |
| NovoCure Ltd. | 341.33M |
| LivaNova Plc | 1.157B |
| ADMA Biologics, Inc. | 431.19M |
| ACADIA Pharmaceuticals, Inc. | 917.27M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 712.33M |
| Total Liabilities (Quarterly) | 176.95M |
| Debt to Equity Ratio | 0.0182 |
| Current Ratio | 3.848 |
| Net Debt Paydown Yield | 0.01% |